🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy

RecruitingNAAges 18 Years - anyAllHelse Forde
NCT05704348 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients planned for bariatric surgery with primary LSG Exclusion Criteria: * Age below 18 yrs * Use of ARM for other reasons than reflux * Previous antireflux surgery * Inability to comprehend and respon to patient related outcome (PRO) questionnaire
💊

What it tests

  • Sleeve gastrectomy with gastropexy
  • Sleeve gastrectomy without gastropexy
📍

Where

4 sites
Helse Forde
Førde, Norway
Aleris Oslo
Oslo, Norway
Volda sjukehus
Volda, Norway
Voss sjukehus
Voss, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy